AI Article Synopsis
- A patient with advanced colon cancer experiencing thrombocytopenia from oxaliplatin chemotherapy underwent mild partial splenic embolization (PSE).
- This procedure helped manage the low platelet count caused by splenomegaly, allowing the patient to continue with systemic chemotherapy.
- The case suggests that mild PSE could be a beneficial option for cancer patients facing similar issues, broadening their treatment possibilities.
Article Abstract
We report the case of a patient with advanced colon cancer receiving oxaliplatin-based chemotherapy that was able to continue systemic chemotherapy by performing mild partial splenic embolization (PSE) for thrombocytopenia caused by splenomegaly due to oxaliplatin. Mild PSE may be useful for thrombocytopenia due to splenomegaly in cancer patients because it provides more treatment opportunities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12664-016-0665-9 | DOI Listing |
Publication Analysis
Top Keywords
mild partial
8
partial splenic
8
splenic embolization
8
thrombocytopenia caused
8
oxaliplatin-based chemotherapy
8
advanced colon
8
colon cancer
8
pse thrombocytopenia
8
successful treatment
4
treatment continuation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!